Product NDC: | 0378-0072 |
Proprietary Name: | Clorpres |
Non Proprietary Name: | clonidine hydrochloride and chlorthalidone |
Active Ingredient(s): | 15; .3 mg/1; mg/1 & nbsp; clonidine hydrochloride and chlorthalidone |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0378-0072 |
Labeler Name: | Mylan Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA071325 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120507 |
Package NDC: | 0378-0072-01 |
Package Description: | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0072-01) |
NDC Code | 0378-0072-01 |
Proprietary Name | Clorpres |
Package Description | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0072-01) |
Product NDC | 0378-0072 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | clonidine hydrochloride and chlorthalidone |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20120507 |
Marketing Category Name | ANDA |
Labeler Name | Mylan Pharmaceuticals Inc. |
Substance Name | CHLORTHALIDONE; CLONIDINE HYDROCHLORIDE |
Strength Number | 15; .3 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC],Increased Diuresis [PE],Thiazide-like Diuretic [EPC] |